STING1 and neoplasm: The engineered EVs enhance the intracellular delivery of cGAS via an endosomal escape mechanism, preferentially activating STING in myeloid cell populations within the TME to trigger a multifaceted shift to a “hot” T-cell-inflamed TME that inhibits tumor growth.